Expired Canadian patentCanada
Methods for treating cardiovascular disease using a soluble ctla4 molecule
CA 2534474 C · Owner: Bristol-Myers Squibb Company · Inventors: Rusnak, James
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compositions and methods for treating cardiovascular system diseases by administering to a subject soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 3, 2004 and granted September 23, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 3, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 3, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 3, 2004
GrantedSeptember 23, 2014
Term endedAugust 3, 2024
Patent numberCA 2534474 C
Classification (IPC)A61K38/17 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.